Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy
- Status
- COMPLETED
- Phase
- N/A
In Vivo Liquid Biopsy of Melanoma (Cytophone)
- Status
- RECRUITING
- Phase
- NA
Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma
- Status
- COMPLETED
- Phase
- N/A
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination
- Status
- TERMINATED
- Phase
- PHASE1
A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Status
- RECRUITING
- Phase
- N/A
Etude rétrospective Monocentrique MATRIX
- Status
- COMPLETED
- Phase
- N/A
LATe TreatmENT Related Toxicity in Melanoma (LATENT)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2
- Status
- COMPLETED
- Phase
- NA
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
WoW - Single- vs Two-staged Excisions of Thin Melanoma
- Status
- RECRUITING
- Phase
- NA
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
- Status
- RECRUITING
- Phase
- N/A